HNF-3 α Antibodies

Santa Cruz Biotechnology provides a broad selection of HNF-3 α monoclonal antibodies for research focused on understanding this critical transcription factor. HNF-3 α Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HNF-3 α, also known as forkhead box A1 (FOXA1), plays a vital role in regulating gene expression during development and is essential for proper liver, pancreas, and kidney function. FOXA1 involvement in metabolic processes and organogenesis makes it significant in both normal physiology and disease states, including diabetes and liver disorders. Understanding FOXA1 function can provide insights into developmental biology and disease mechanisms. Research has shown that FOXA1 acts as a pioneer factor, making chromatin accessible for other transcription factors. FOXA1 has emerged as a key player in hormone-dependent cancers, particularly in breast and prostate cancer development. HNF-3 α research continues to reveal new aspects of transcriptional regulation and tissue development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FOXA1's role in health and disease.